Wikidata

(Q88139733)

English

Efficacy and Safety of Bococizumab (RN316/PF-04950615), a Monoclonal Antibody Against Proprotein Convertase Subtilisin/Kexin Type 9, in Hypercholesterolemic Japanese Subjects Receiving a Stable Dose of Atorvastatin or Treatment-Naive　- Results From

scientific article published on 23 May 2017

In more languages

Statements

title
Efficacy and Safety of Bococizumab (RN316/PF-04950615), a Monoclonal Antibody Against Proprotein Convertase Subtilisin/Kexin Type 9, in Hypercholesterolemic Japanese Subjects Receiving a Stable Dose of Atorvastatin or Treatment-Naive　- Results From a Randomized, Placebo-Controlled, Dose-Ranging Study (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
28539539
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28539539%20AND%20SRC:MED&resulttype=core&format=json
retrieved
21 March 2020
author name string

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q88139733&oldid=1253954746"